Failure to Document Provider Rationales for Disagreeing With Monthly MRR Recommendations
Penalty
Summary
Surveyors identified a deficiency in the facility’s handling of monthly medication regimen review (MRR) recommendations, specifically the failure of providers to document rationales when disagreeing with or not clearly responding to pharmacist recommendations for two residents. For one resident admitted on 7/6/25, multiple MRRs contained pharmacist recommendations regarding psychotropic medications, potential gradual dose reductions (GDRs), monitoring for adverse effects, and evaluation of medication tolerability in the context of documented allergies. On 12/31/24, the pharmacist recommended considering a Trazodone GDR for insomnia; the provider marked “disagree” but did not document a rationale. On 3/30/25, the pharmacist recommended considering a clozapine GDR; again, “disagree” was checked without a rationale. On 4/28/25, the pharmacist suggested monitoring for bruising/bleeding with ASA/Clopidogrel, and “disagree” was checked with no rationale. On 5/4/25, the pharmacist requested evaluation of tolerability to Amoxicillin and Aspirin given penicillin and Excedrin allergies, and documentation was noted but neither “agree” nor “disagree” was selected. On 7/6/25, the pharmacist requested evaluation of Aspirin use with an Excedrin allergy and clarification of a “psych disorder” diagnosis per CMS, but there was no provider response. On 7/25/25, the pharmacist noted that an olanzapine “psych disorder” diagnosis would trigger an MDS quality indicator and recommended review of diagnosis and usage for possible GDR, as well as a risk vs. benefit analysis for methocarbamol per Beers criteria; neither “agree” nor “disagree” was selected and no rationale was documented. The NP (E7) confirmed she reviews pharmacist recommendations, consults with the pharmacist and psychiatric NP for psychotropic changes, and acknowledged that a rationale should be documented when a provider disagrees. The CNO (E11) confirmed that the attending physician failed to document actions taken or not taken in response to identified irregularities. For a second resident admitted on 10/13/23, the clinical record showed a 7/1/25 MRR in which the pharmacist recommended that lorazepam 0.5 mg twice daily be considered for GDR. There was no rationale documented by the provider in response to this recommendation. The NP (E7) stated she reviews monthly GDR recommendations, discusses findings with the psychiatric NP, and then documents her rationale on the pharmacy GDR form and in the electronic medical record. The DON (E3) reported that quarterly reviews of MRRs are conducted and findings are discussed with the medical director, and confirmed that the medical director did not include a rationale for the lorazepam recommendation. These interviews and record reviews demonstrated that the facility did not consistently ensure that providers documented rationales when disagreeing with or failing to clearly respond to pharmacist-identified medication irregularities during the MRR process.
We Help Long-Term Care Teams Stay Survey-Ready
We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.